Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-017909
Filing Date
2025-02-11
Accepted
2025-02-11 16:14:58
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sage-20241231.htm   iXBRL 10-K 4210537
2 EX-10.30 sage-ex10_30.htm EX-10.30 134164
3 EX-10.31 sage-ex10_31.htm EX-10.31 63241
4 EX-10.32 sage-ex10_32.htm EX-10.32 122990
5 EX-10.33 sage-ex10_33.htm EX-10.33 29031
6 EX-10.34 sage-ex10_34.htm EX-10.34 105918
7 EX-10.35 sage-ex10_35.htm EX-10.35 13609
8 EX-19.1 sage-ex19_1.htm EX-19.1 91127
9 EX-21.1 sage-ex21_1.htm EX-21.1 14584
10 EX-23.1 sage-ex23_1.htm EX-23.1 3146
11 EX-31.1 sage-ex31_1.htm EX-31.1 15765
12 EX-31.2 sage-ex31_2.htm EX-31.2 15771
13 EX-32.1 sage-ex32_1.htm EX-32.1 10147
14 EX-97 sage-ex97.htm EX-97 33409
15 GRAPHIC img94151232_0.jpg GRAPHIC 862096
16 GRAPHIC img94151232_1.jpg GRAPHIC 565837
17 GRAPHIC img203896447_0.jpg GRAPHIC 24906
18 GRAPHIC img203896447_1.jpg GRAPHIC 24906
19 GRAPHIC img205743489_0.jpg GRAPHIC 24906
  Complete submission text file 0000950170-25-017909.txt   20533366

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sage-20241231.xsd EX-101.SCH 1848843
108 EXTRACTED XBRL INSTANCE DOCUMENT sage-20241231_htm.xml XML 3401719
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36544 | Film No.: 25609981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)